TECHWIRE 30
(CIX: WRAL30)  1,094.59  down arrow-4.11  (-0.37 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: Apple)  98.38  down arrow-0.64  (-0.65 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: QUINTILES)  55.94  up arrow+1.14  (2.08 %)  Updated: 04:15 PM EDT, Jul 29 2014
(OP: BASF SE)  108.47  up arrow+0.34  (0.31 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: BioCryst)  12.25  up arrow+0.51  (4.34 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: BioDelivery)  13.05  up arrow+0.5  (3.98 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: CEMP)  9.70  up arrow+0.28  (2.97 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: Cisco Systems)  25.71  down arrow-0.21  (-0.81 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: Cree)  48.25  down arrow-0.26  (-0.54 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: DARA)  1.33  down arrow-0.04  (-2.92 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: EMC CORPORATION)  29.47  down arrow-0.2  (-0.67 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NQ: Extreme Networks)  4.79  down arrow-0.04  (-0.83 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: FB)  73.71  down arrow-1.21  (-1.62 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: GLAXOSMITHKLINE)  48.03  down arrow-0.17  (-0.35 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NQ: GOOG)  585.61  down arrow-4.99  (-0.84 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: IBM)  194.57  down arrow-1.21  (-0.62 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NY: LH)  105.38  down arrow-0.34  (-0.32 %)  Updated: 04:15 PM EDT, Jul 29 2014
(OP: Lenovo Group)  27.70  down arrow-0.14  (-0.49 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: MRK)  58.58  up arrow+0.61  (1.05 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NQ: Microsoft Corp)  43.89  down arrow-0.09  (-0.19 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: NTAP)  38.58  up arrow+0.03  (0.08 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: NOVARTIS AG)  88.21  up arrow+0.44  (0.5 %)  Updated: 04:15 PM EDT, Jul 29 2014
(OP: Novozymes A/S)  50.44  down arrow-0.2  (-0.39 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: PFIZER)  29.73  down arrow-0.37  (-1.23 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NQ: Pozen)  7.28  up arrow+0.35  (5.05 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NY: RED HAT)  56.15  down arrow-0.55  (-0.97 %)  Updated: 04:15 PM EDT, Jul 29 2014
(NQ: BBRY)  9.51  down arrow-0.44  (-4.42 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: Salix)  131.48  up arrow+0.16  (0.12 %)  Updated: 05:20 PM EDT, Jul 29 2014
(NQ: SQI)  15.11  up arrow+0.39  (2.65 %)  Updated: 05:20 PM EDT, Jul 29 2014

Posts tagged “UNC-CH”

February 5

Premium Lock Kitware lands $1.9M for brain surgery simulator

Brain power UNC is among the collaborators on the National Institutes of Health funded project and the UNC Department of Neurosurgery will validate the brain surgery simulation technology.

Updated February 4

Premium Lock Building bridges to China, the country 'definitely the hardest to manage'

Michael Jacobs, a business executive and professor at UNC's Kenan-Flagler School of Business who also is a former U.S. Treasury official, recently taught finance in Beijing. And he returned to his North Carolina home surprised by many things he discovered. His students want to live in the U.S. "for better jobs, clean air and Facebook." And non-Chinese businesses face multiple barriers. In the third of a three-part series about building business bridges to China, Jacobs talks with WRALTechWire's Grace Ueng.

The Forbidden City in Beijing The Forbidden City in Beijing

Updated January 22

Premium Lock RTI partners on epilepsy work; SAS ranked in report; lawyers use cloud tools; Kenan-Flagler dean recommended; Abbott gets new trial

Bulldog In our Bulldog Blog's latest life sciences and technology update: RTI partners on epilepsy network; SAS makes ranking; lawyers use more cloud tools; Kenan-Flagler dean recommended; AbbVie gets new drug trial.

Updated January 16

Premium Lock New chip initiative charges up Triangle's Cleantech Cluster

President Obama's announcement to invest $70 million in federal dollars in research through a consortium of universities and private sector firms led by NCSU delivered a jolt of good news to the Triangle's fast-growing cleantech industry. RTP has become a hub for greener energy research, and the head of the Research Triangle Cleanteach Cluster says the "Next Generation Power Electronics Innovation Institute" could bring more jobs as well as investment to the region.

President Obama with Marc Hoffman, Senior Mechanical Engineer at Vacon President Obama with Marc Hoffman, Senior Mechanical Engineer at Vacon

January 14

Premium Lock UNC converts solar to hydrogen power - with help from NCSU

Researchers at UNC-Chapel Hill say they have found a way to turn solar power into a 24-hour-a-day power source by using the sun's energy to separate water molecules and create hydrogen fuel. In making the breakthrough, they received a powerful boost from scientists at N.C. State.

UNC researchers separate hydrogen for power UNC researchers separate hydrogen for power

January 10

Premium Lock UNC-CH spinout NeuroGate lands $25,000 Epilepsy Foundation grant, endorsement

DNA  Chapel Hill development-stage pharmaceutical company NeuroGate Therapeutics, a spinout from the University of North Carolina at Chapel Hill, has been awarded a $25,000 grant from the Epilepsy Foundation to help the company develop its unique treatment for the debilitating condition.

January 6

Premium Lock NCSU-UNC team may have breakthrough in war on cancer by using nanotechnology

If the war on cancer is won - finally - someday, a team of scientists and students in the joint biomedical engineering program at N.C. State and UNC-Chapel Hill could be a significant reason. But their technology approach is different than the high-profile nanotech program developed by Dr. Joseph Simone and Liquidia. In an exclusive interview with WRALTechWire, the lead author of a new paper describes the potentially big breakthrough using small, small particles.

Nanotech vs. cancer in mice Nanotech vs. cancer in mice

Updated November 21, 2013

Premium Lock As NC Chamber preps economic development 'Dashboard,' UNC projects 'megalopolis' in 2050

The North Carolina Chamber will unveil an economic development "Dashboard" created by RTI International on Dec. 3 as part of its Vision 2030 project. Those involved may want to look at new demographic data compiled at UNC which projects where most people in the state will be living in 2050. Are you ready for a Charlotte-Triad-Triangle megalopolis?

Click here to open the YouTube video in a new window.

Tags: UNC-CH
November 18, 2013

Premium Lock UNC's Gillings School showcases public health startups during entrepreneurship week

Plenty of tech and biotech companies have been founded at the University of North Carolina at Chapel Hill but the university has also proved to be a fertile breeding ground for entrepreneurship in public health. Read about four public health spinouts from UNC's Gillings School of Public Health.

Store Mapper software from Counter Tools Store Mapper software from Counter Tools

November 11, 2013

Premium Lock Changing times: GSK sells bad with good to doctors in safety push

GSK When 100 of the top lung doctors in the U.S. gathered in Houston recently to learn about GlaxoSmithKline's new respiratory drug, one message rang loud and clear: Don't ignore the pneumonia risk. It's part of a new "Patient First" strategy from GSK.

Updated November 11, 2013

Premium Lock Exclusive: NC program delivers new breed of IT pros for today's schools

The Certified Educational Chief Technology Officer (CeCTO) program finished its fourth cohort and welcomed 20 new CeCTOs and 11 Leaders of the 21st Century last week in Chapel Hill.

CeCTO Class of 2013 CeCTO Class of 2013

November 6, 2013

Premium Lock Two UNC scientists among eight winners in GSK 'drug hunters' competition

Two University of North Carolina scientists are among the winners in a GSKcompetition designed to find potential new drugs in places other than pharmaceutical company labs. Read about what this means for the scientists and for GSK.

GSK's R&D facility in RTP GSK's R&D facility in RTP

October 30, 2013

Premium Lock Kenan Institute director DeSimone to step down at end of the year

Joseph DeSimone Joseph DeSimone, whose nanotechnology research in University of North Carolina at Chapel Hill labs formed the basis for spinout Liquidia Technologies, will step down as director of UNC's Kenan Institute of Private Enterprise 18 months after taking the top position.

Updated October 23, 2013

Premium Lock Cree shares plunge 20% after earnings report; 2 analysts cut rating

Cree reports revenues of $391 million and earnings of 39 cents per share, both figures topping Wall Street analysts' expectations by a considerable margin. However, investors expected higher numbers for the current quarter. Shares opened sharply lower Wednesday, and two analysts cut their ratings on the stock.

Cree's $10 LED bulb    Cree's $10 LED bulb

Updated October 22, 2013

Premium Lock OxyBio shares close up 30% after trifecta: Acquires pharma firm, hires CEO, adds potential $600M drug

Wall Street likes this deal. Morrisville-based OxyBio says it is buying privately held Phyxius Pharma for some $4.8 million in stock and is naming the co-founder and CEO of that company as its chief executive officer. It's also acquiring the rights to a drug that could be worth $600 million a year.

John Kelley to lead combined company John Kelley to lead combined company

Updated October 22, 2013

Premium Lock UNC, Duke land combined $104M to speed up health research

Healthcare   The National Institutes of Health awards UNC-CH a five-year grant for programs, drug development and technology targeting the improvement of healthcare across North Carolina. RTI International and N.C. A&T will share in the contract. Duke, meanwhile, receives a $47 million grant.

October 14, 2013

Premium Lock UNC Health Care picks IBM analytics in effort to improve care, cut costs

In an effort to cut costs, reduce the number of re-admissions and improve quality of life for patients, the UNC Health Care system is going to utilize analytics from IBM.

IBM touts "Smarter Care" IBM touts "Smarter Care"

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll